Thani Jambulingam serves as Executive at Virpax Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Thani Jambulingam has executed 1 insider transactions totaling $716, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 17, 2021 involved purchasing 100 shares valued at $716.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 17, 2021 | VRPX | $716 | Purchase | 100 | $7.16 | Discretionary |
Thani Jambulingam currently holds 100 shares of Virpax Pharmaceuticals, Inc. (VRPX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thani Jambulingam has been a net buyer of VRPX stock. They have purchased $716 and sold $0 worth of shares.
Thani Jambulingam's most recent insider trade was on Feb 17, 2021, when they purchased 100 shares at $7.16 per share.
Get notified when new Form 4 filings are submitted